\-\ Texto\\:\\ \ \(0\)\
\-\ examination\\:\\ back\\:\\ 5\\ cm\\ firm\\,\\ indurated\\ erythematous\\ tumor\\ with\\ 2\\ cm\\ area\\ of\\ central\\ necrosis\\.\ \(0\)\
\-\ labs\\:\\ ct\\ from\\ december\\ 2002\\ reveals\\ increasing\\ right\\-sided\\ apical\\ lung\\ tumor\\ with\\ apical\\ collapse\\ and\\ scar\\ formation\\ with\\ worsening\\ right\\-sided\\ pleural\\ effusion\\,\\ as\\ well\\ as\\ osseous\\ lesions\\ in\\ the\\ t5\\ and\\ l1\\ vertebrae\\ and\\ pelvis\\.\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ a\\ carcinoma\\ with\\ cytomorphologic\\ features\\ consistent\\ with\\ the\\ patient\\'s\\ prior\\ bronchoalveolar\\ carcinoma\\.\\ immunohistochemistry\\ was\\ strongly\\ positive\\ for\\ ttf\\-1\\ and\\ ck7\\ but\\ negative\\ for\\ ck20\\;\\ findings\\ compatible\\ with\\ lung\\ carcinoma\\.\ \(0\)\
\-\ case\\ 6\\,\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ conference\\,\\ 2003\\)\\ metastatic\\ lung\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ other\\ neoplasms\ \(1\)\
\-\ \\â\\€\\¢\\ infections\ \(1\)\
\-\ history\\:\\ a\\ 70\\ year\\ old\\ caucasian\\ male\\ with\\ non\\-small\\ cell\\ bronchoalveolar\\ carcinoma\\ since\\ may\\ 2000\\ presented\\ with\\ a\\ necrotic\\ nodule\\ on\\ his\\ back\\.\\ his\\ cancer\\ was\\ initially\\ responsive\\ to\\ chemotherapy\\ but\\ became\\ chemoresistant\\ and\\ was\\ discontinued\\ two\\ weeks\\ prior\\ to\\ his\\ presentation\\ to\\ dermatology\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bronchoalveolar\\:\\ 0\\.24150388971187975\ \(0\)\
\-\ carcinoma\\:\\ 0\\.23399815519973555\ \(0\)\
\-\ apical\\:\\ 0\\.20108835518366447\ \(0\)\
\-\ dermatology\\:\\ 0\\.19138912111563502\ \(0\)\
\-\ lung\\:\\ 0\\.17847860884456848\ \(0\)\
\-\ his\\:\\ 0\\.1779400248026026\ \(0\)\
\-\ cytomorphologic\\:\\ 0\\.15640348906863083\ \(0\)\
\-\ ck7\\:\\ 0\\.15640348906863083\ \(0\)\
\-\ ck20\\:\\ 0\\.15640348906863083\ \(0\)\
\-\ chemoresistant\\:\\ 0\\.15640348906863083\ \(0\)\
\-\ with\\:\\ 0\\.15320369943456563\ \(0\)\
\-\ immunohistochemistry\\:\\ 0\\.14069389642833915\ \(0\)\
\-\ conference\\:\\ 0\\.13756803551199168\ \(0\)\
\-\ back\\:\\ 0\\.13045110393868342\ \(0\)\
\-\ indurated\\:\\ 0\\.12431187373362622\ \(0\)\
\-\ discontinued\\:\\ 0\\.12075194485593987\ \(0\)\
\-\ december\\:\\ 0\\.11873258195535248\ \(0\)\
\-\ t5\\:\\ 0\\.11692620028654516\ \(0\)\
\-\ 27th\\:\\ 0\\.11529212930108795\ \(0\)\
\-\ cm\\:\\ 0\\.1123352973537937\ \(0\)\
\-\ responsive\\:\\ 0\\.11115746162291643\ \(0\)\
\-\ prior\\:\\ 0\\.10943854219439887\ \(0\)\
\-\ l1\\:\\ 0\\.10547642017698702\ \(0\)\
\-\ tumor\\:\\ 0\\.10231014727046295\ \(0\)\
\-\ was\\:\\ 0\\.10225280345375896\ \(0\)\
\-\ vertebrae\\:\\ 0\\.10121660764625344\ \(0\)\
\-\ and\\:\\ 0\\.10104586186835762\ \(0\)\
\-\ erythematous\\:\\ 0\\.09927361355201944\ \(0\)\
\-\ histopathology\\:\\ 0\\.0986719809912298\ \(0\)\
\-\ strongly\\:\\ 0\\.09837890088559353\ \(0\)\
\-\ compatible\\:\\ 0\\.09780735567153438\ \(0\)\
\-\ 2000\\:\\ 0\\.09780735567153438\ \(0\)\
\-\ uniformed\\:\\ 0\\.0975285728025948\ \(0\)\
\-\ but\\:\\ 0\\.09672450438236882\ \(0\)\
\-\ services\\:\\ 0\\.09594485359687788\ \(0\)\
\-\ became\\:\\ 0\\.09594485359687788\ \(0\)\
\-\ necrotic\\:\\ 0\\.0952046766968978\ \(0\)\
\-\ 2002\\:\\ 0\\.09359257210609005\ \(0\)\
\-\ scar\\:\\ 0\\.09232200806627724\ \(0\)\
\-\ collapse\\:\\ 0\\.09172037550548762\ \(0\)\
\-\ neoplasms\\:\\ 0\\.09113914124416378\ \(0\)\
\-\ annual\\:\\ 0\\.09039359905899562\ \(0\)\
\-\ firm\\:\\ 0\\.08866032952093524\ \(0\)\
\-\ 2003\\:\\ 0\\.08801328032781632\ \(0\)\
\-\ caucasian\\:\\ 0\\.08693657340326799\ \(0\)\
\-\ infections\\:\\ 0\\.08635037036385443\ \(0\)\
\-\ 70\\:\\ 0\\.08074708310415707\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.07993534481869084\ \(0\)\
\-\ features\\:\\ 0\\.07869311924595561\ \(0\)\
\-\ as\\:\\ 0\\.07857946088655988\ \(0\)\
\-\ osseous\\:\\ 0\\.07805973122382127\ \(0\)\
\-\ formation\\:\\ 0\\.07753485037451573\ \(0\)\
\-\ nodule\\:\\ 0\\.07719364968730938\ \(0\)\
\-\ increasing\\:\\ 0\\.07702556237352821\ \(0\)\
\-\ initially\\:\\ 0\\.07669425218603813\ \(0\)\
\-\ necrosis\\:\\ 0\\.07475711854945086\ \(0\)\
\-\ worsening\\:\\ 0\\.0746840064187039\ \(0\)\
\-\ reveals\\:\\ 0\\.07439463636509176\ \(0\)\
\-\ pleural\\:\\ 0\\.07362316693506472\ \(0\)\
\-\ to\\:\\ 0\\.07334942271121468\ \(0\)\
\-\ effusion\\:\\ 0\\.07262415998412684\ \(0\)\
\-\ since\\:\\ 0\\.0708436767623568\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.06944446929458391\ \(0\)\
\-\ biopsy\\:\\ 0\\.06855431192448326\ \(0\)\
\-\ pelvis\\:\\ 0\\.06840191297721869\ \(0\)\
\-\ labs\\:\\ 0\\.06775673701749999\ \(0\)\
\-\ presentation\\:\\ 0\\.06732388676763423\ \(0\)\
\-\ central\\:\\ 0\\.06530980161641238\ \(0\)\
\-\ cancer\\:\\ 0\\.06514171430263123\ \(0\)\
\-\ positive\\:\\ 0\\.06444517629671695\ \(0\)\
\-\ area\\:\\ 0\\.06335625364762008\ \(0\)\
\-\ examination\\:\\ 0\\.06258267422206044\ \(0\)\
\-\ negative\\:\\ 0\\.06054731060292618\ \(0\)\
\-\ for\\:\\ 0\\.059284858054287584\ \(0\)\
\-\ weeks\\:\\ 0\\.058613457947820274\ \(0\)\
\-\ the\\:\\ 0\\.05854393048337062\ \(0\)\
\-\ two\\:\\ 0\\.058078959197912394\ \(0\)\
\-\ shows\\:\\ 0\\.05740013859784528\ \(0\)\
\-\ presented\\:\\ 0\\.0570314196841782\ \(0\)\
\-\ lesions\\:\\ 0\\.05616764867689685\ \(0\)\
\-\ cell\\:\\ 0\\.055946105151873524\ \(0\)\
\-\ metastatic\\:\\ 0\\.05363840692924262\ \(0\)\
\-\ consistent\\:\\ 0\\.05302940439512944\ \(0\)\
\-\ other\\:\\ 0\\.05078910950186092\ \(0\)\
\-\ may\\:\\ 0\\.04921604319115466\ \(0\)\
\-\ case\\:\\ 0\\.049133655869335865\ \(0\)\
\-\ findings\\:\\ 0\\.04826822214555011\ \(0\)\
\-\ well\\:\\ 0\\.04735524149239304\ \(0\)\
\-\ male\\:\\ 0\\.04354432162662718\ \(0\)\
\-\ from\\:\\ 0\\.03884201320073607\ \(0\)\
\-\ history\\:\\ 0\\.037365261222462004\ \(0\)\
\-\ ct\\:\\ 0\\.03723337773615746\ \(0\)\
\-\ patient\\:\\ 0\\.03180942991128807\ \(0\)\
\-\ year\\:\\ 0\\.030140034086831056\ \(0\)\
\-\ on\\:\\ 0\\.02953727832232785\ \(0\)\
\-\ old\\:\\ 0\\.02894486595507405\ \(0\)\
\-\ in\\:\\ 0\\.024329465668180655\ \(0\)\
\-\ of\\:\\ 0\\.01913902686532925\ \(0\)\
